Clinical Trial Results:
Development of humoral and cellular immune response in infants after pneumococcal conjugate vaccinations with
Synflorix® or Prevenar-13®
Summary
|
|
EudraCT number |
2011-002103-15 |
Trial protocol |
NL |
Global completion date |
13 Dec 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
22 Jul 2022
|
First version publication date |
25 Feb 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
Memory B cells after PCV10 and PCV13 Immunogenicity induced by PCV10 or PCV13 around the 11-month booster in Dutch infants |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.